BriaCell Therapeutics Corp. Warrant
BCTXZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.08M
Close$
$1.97
1491.4% upside
Current Fair Value
1491.4% upsideUndervalued by 1491.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.08 Million |
|---|---|
| Enterprise Value | $-5,804,779.00 |
| Earnings per Share | $-7.07 |
| Beta | 1.54 |
| Outstanding Shares | 8,708,029 |
Return
| Return on Equity | -148.29% |
|---|---|
| Return on Assets | -128.23% |
| Return on Invested Capital | -130.04% |
Valuation & Multiples
| P/E Ratio | -0.33 |
|---|---|
| PEG | -0.66 |
| Price to Sales | - |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BriaCell Therapeutics Corp
17 employees
CEO: William V. Williams
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.